The Boston Business Journal reports that Qteros Inc., a Marlborough, Massachusetts company making cellulosic ethanol, will open a new research and development facility in Chicopee, Massachusetts by the end of 2010. CEO John McCarthy tells the Journal the 15,000 square-foot plant will allow for fermentation of biomass on a larger scale than is now possible . . . → Read More: Cellulosic Ethanol Company to Build R&D Center
|
|||||
       |
The FundingPost.com Angel Investor and Early-Stage VC Event in Washington, DC today drew a full house of 125+ entrepreneurs and investors to the K Street law offices of Bingham McCutchen. Participants heard elevator pitches from 15 entrepreneurs, ranging from a day-spa that features exotic destination themes, to a genetics lab seeking funds for a joint . . . → Read More: Financing Tips from Angel and VC Investors I will be at the DC Angel Investor and Venture Capital Conference this afternoon. Regular posting will resume tomorrow. Venture capital (VC) funding for health care start-up businesses in the U.S. Midwest rose slightly in the first half of 2010, compared to the first half of 2009, according to a report by BioEnterprise, a Cleveland, Ohio organization supporting health care entrepreneurs. In the first half of 2010, VC companies invested $412 million in health . . . → Read More: Midwest Health Care Venture Funding Flat in 2010 (Photos8.com) Envoy Therapeutics Inc., a drug discovery company in Jupiter, Florida says it has begun a research collaboration with The Scripps Research Institute to identify new drugs for Parkinson’s disease that have greater efficacy and safety compared to current therapies. Using funding provided by Envoy, scientists at the two organizations will apply Scripps-Florida’s . . . → Read More: Biotech Company to Partner with Scripps on Parkinson’s Drugs Ten venture capital companies are taking part in a program to increase access to funding for start-up companies in the North Texas Enterprise Center (NTEC) in Frisco, near Dallas, Texas. NTEC is a not-for-profit business accelerator, providing services and support to medical technology and clean technology start-up companies. One of the purposes of the program . . . → Read More: Venture Companies Partner With Texas Technology Start-Up Center LifeAct, coupled to green fluorescent protein, colors the actin cytoskeleton (Max Planck Institute for Biochemistry) The Max Planck Society, through its technology transfer affiliate Max Planck Innovation GmbH in Munich, Germany, has awarded an exclusive license for the peptide LifeAct to ibidi GmbH, a provider of cell analysis products, located in Martinsried, Germany. . . . → Read More: Max Planck to License Peptide for Cytoskeleton Research AFS Trinity Power Corporation in Bellevue, Washington says it received a patent from the U.S. Patent and Trademark Office that allows for the combination of ultracapacitors and other devices on a hybrid vehicle’s drive train. This innovation, says the company, will mean plug-in electric vehicles can run longer on smaller batteries. The patent, says the . . . → Read More: Patent Awarded for Technology to Extend Hybrid Battery Life (A. Kotok) A drug made by Seaside Therapeutics Inc. of Cambridge, Massachusetts has shown results controlling symptoms of fragile X syndrome, an inherited disorder known to cause autism. The findings were reported this past weekend at a meeting of the National Fragile X Foundation. The results of the randomized, double-blind, placebo-controlled Phase 2 . . . → Read More: Clinical Trial Shows Drug Impact on Fragile X Syndrome A group of scientists from the Agricultural Research Service (ARS) in the U.S. Department of Agriculture and Filtrexx International of Grafton, Ohio, have improved on the methods for removing contaminants from storm water runoff. The runoff from storm water is particularly vulnerable to pollution in industrial areas or near construction sites. Current methods use “filter . . . → Read More: Collaboration Improves Filters for Storm Water Runoff |
||||
|
Copyright © 2024 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||
Comments are closed 
RSS - Posts
You must be logged in to post a comment.